M&A Consulting for Biotech, Pharma and Diagnostics – Due Diligence, Integration, Asset Transfer and Tech Transfer

What We Do

At LBBAL Alianza, we support biotechnology, pharmaceutical and diagnostic companies through all stages of an M&A process — from due diligence to post-M&A integration and technology transfer. Our team combines scientific rigor, strategic vision with a proven track record in global acquisitions and technology transfers across leading biopharma organisations.

How We Do It

Buy- and sell-side due diligence, with expert review of R&D plans, licensing portfolios, alliances and collaborations, experimental protocols, and regulatory, clinical development and commercialisation strategies.

Post-M&A planning and integration led by senior experts, ensuring strategic and regulatory objectives are achieved.

Tech transfer services adapted to each development stage — from asset purchases to licensing deals — supported by hands-on experience in both research and GMP manufacturing environments.

Who We Help

Our M&A and diligence services are designed for:

Biotech startups and scale-ups seeking scientific validation and investment readiness.

Large pharmaceutical and diagnostic companies managing complex integration processes.

Investment funds and venture capital firms requiring operational and scientific due diligence.

Law firms specialising in biotech/pharma that need technical and strategic partnering support.

Benefits for Our Clients

Reduced operational, regulatory, technical and strategic risks

Agile execution without compromising quality

International credibility that facilitates investment and collaboration

Practical negotiation approach leading to solid, sustainable deals and partnerships

Internal team support to maximise their efficiency and focus

Testimonials

Are you leading an M&A process in biotech, pharma or diagnostics?